Percutaneous implantation of arterial port-a-cath via trans-subclavin access

Anticancer Research

Volumn 19, Issue 6 C, 1999, Pages 5667-5671

  Zanon, Claudio ^a   Grosso, Maurizio ^a   Clara, Renzo ^a   Chiappino, Isabella ^a   Mancini, Andrea ^a   Mussa, Antonio ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Advanced cancer; Arterial port a cath; Colorectal liver metastases; Hepatic artery infusion; Regional chemotherapy

Indexed keywords

ADULT; ANEURYSM; ARTERY CATHETERIZATION; ARTERY THROMBOSIS; ARTICLE; BILE DUCT CANCER; CANCER CHEMOTHERAPY; CLINICAL TRIAL; COLORECTAL CANCER; FEMALE; GASTRODUODENAL ARTERY; HEPATIC ARTERY; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; LAPAROTOMY; LIVER CANCER; LIVER METASTASIS; LOCAL ANESTHESIA; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PRIORITY JOURNAL; SPLEEN ARTERY; SUBCLAVIAN ARTERY;

ANEURYSM; ANTINEOPLASTIC AGENTS; CATHETERIZATION; CATHETERS, INDWELLING; FEASIBILITY STUDIES; FEMALE; FLUOROSCOPY; HEPATIC ARTERY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; SPLENIC ARTERY; SUBCLAVIAN ARTERY; THROMBOSIS;

EID: 0033382095     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Sugihara K, Hojo K, Moriya Y, et al: Pattern of recurrence after hepatic resection for colorectal metastases. Br J Surg 80: 1032-1035, 1993.
2. Scheele J, Stangl R, Altendorf-Hofmann A, Paul M: Resection of colorectal liver metastases. World J Surg 19; 59-71, 1995.
3. Kemeny N, Daly J, Reichman B, et al: Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial. Ann Intern Med 107(4): 459-465, 1987.
4. Chang AE, Schneider PD Sugarbaker PH, et al: A prospective randomized trial of regional vs systemic continuous 5-FU chemotherapy in the treatment of colorectal metastases. Ann Surg 206: 685-693, 1987.
5. Hohn DC, Stagg RJ, Friedman MA, et al: A randomized trial of continuous intravenous vs hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver. The Northern California Oncology Trial. J Clin Oncol 7: 1646-1654, 1989.
6. Rougier P, Laplanche A, Huguier M, et al: Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long term results of a prospective randomixed trial. J Clin Oncol 10: 1112-1118, 1992.
7. Martin JK Jr, O'Connell MJ, Wieand HS, et al: Intra-arterial floxuridine vs. systemic fluorouracil for hepatic metastases from colorectal cancer: a randomized trial. Arch Surg 125: 1022-1027, 1990.
8. Meta-Analysis Group in Cancer: Reappraisal of hepatic arterial insfusion in the treatment of nonresectable liver metastases from colorectal cancer. J Natl Cancer Inst 88: 252-258, 1996.
9. Ensminger WD, Rosowsky A, Raso V, et al: A clinical pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2'- deoxyurinine and 5-fluorounicil. Cancer Res 38: 3784-3792, 1978.
10. Tanikawa K: Non invasive locoregional therapy for hepatocellular carinoma. Semin Surg Oncol 12(3): 189-192, 1996.
11. Nakashima K, Kitano S, Kim YL, et al: Postoperative adjuvant arterial infusion chemotherapy for patients with hepatoellular carcinoma. Hepato-Gastroenterol 43(12): 1410-1414, 1996.
12. Muchmore JH, Preslan JE, George WJ: Regional chemotherapy for inoperable pancreatic carcinoma. Cancer 78(3 Suppl): 664-673, 1996.
13. Theodors A, Bukowski R, Hewlett J, et al: Intermittent regional infusion of chemotherapy for pancreatic adenocarcinoma. Phase I and 11 pilot study. Am J Clin Oncol 5(5): 555-558, 1982.
14. Arai Y, Ynaha Y, Takeuchi Y, Ariyoshi Y: Intermittent hepatic arterial infusion of high-dose 5FU on a weekly schedula for liver metastases from colorectal cancer. Cancer Chemother Pharmacol 40: 526-530, 1997.
15. Oi H, Kishimoto H, Matsushita M: Percutaneous implantation of hepatic artery infusion reservoir by sonographically guide left subclavian artery puncture. Am J Roentegenol 166: 821-822 1996.
16. Minoyama A, Yoshikawa M, Ebara M. et al: Study of repeated arterial infusion chemotherapy with subcutaneously implanted reservoir for advanced hepatocellular carcinoma. J Gastroenterol 30: 356-366, 1995.
17. Wacker FK, Landgraf JB, Wagner A, et al: Minimally invasive catheter implantation for regional chemotherapy of the liver: a new percutaneous transsubclavian approach. Cardiovasc Intervent Radiol 20: 128-132, 1997.
18. Strecker EPK, Boos IBL, Ostheim-Dzerowyc W, et al: Percutaneously implantable catheter-port system: preliminary technical results. Radiol 202: 574-577, 1997.
19. Matsumada T, Yamagishi H, Bong Jin M, et al: Laparotomy versus interventional radiological procedures for implantation of arterial infusion devices. Surg Today 23: 223-227, 1997.
20. Gemer CT, Boese-Landgraf J, Albrecht D, et al: Der vollimplantierbare minimal-invasive Arteria hepatica-Katheter zur locoregionaren Chemoterapie nicht-reseklabler Lebermetastasen bei Defecten von Konventionell implantierten. Therapiekathetern Chirurg 67: 458-462, 1996.
21. Castaing D, Azoulay D, Fecteau AH, et al: Implantable hepatic arterial infusion device: placement without laparotomy via an intercostal artery. Am Coll Surg 187(5): 565-568, 1998.
22. Zanon C, M. Grosso M: Transaxillary access to perform hepatic artery infusion (HAI) for secondary or primitive hepatic tumours lletterl. Eur J Cancer 32(10): 1824-1825 1996.
23. Conlon KC, Klimstra DS, Brennan MF Long term survival after curative resection for pancreatic ductal adenocarcinoma. Ann Surg 223(3): 173-179, 1996.
24. Nordback IH, Pitt HA, Coleman J, et al: Unresectable hilar cholangi-ocarcinoma: percutaneous versus operativepalliation. Surgery 115(5): 597-603, 1994.
25. Henson De, Albores Saavedra J, Corte D: Carcinoma of the extrahepatic bile ducts: hystologic types, stage of disease, grade and sulvival rates. Cancer 70: 1498-1501, 1992.
26. Durand Zaleski I, Roche B, Buyse M et al: Economic implications of hepatica arterial infusions chemotherapy in treatmento of nonresectable colorectal liver metastases. Meta-Analysis Group in Cancer. J Natl Cancer Inst 89(11): 790-795, 1997.
27. Arai Y,' the study of catheter placement into the hepatic artery via the left subclavian artery for hepatic infusion therapy. J Nagoya City Univ Med Assoc 39: 453-464, 1988.
28. Noda M, Kusunoki M, Yanagai H, et al: Hepatic artery-biliary fistula during infusion chemotherapy. Hepato-Gastroenterol 43(11): 1387-1389, 1996.
29. Carrasco CH, Freeny PC, Chuang VP, Wallace S Chemical cholecystitis associated with hepatic artery infusion chemotherapy. AJR 141: 703-706, 1996.
30. Kemeny N, Conti JA, Cohen A, et al: Phase 2 study of hepatic arterial floxuridine, leucovorin and dexamethasone for unresectable liver metastases from colorectal carcinoma. J Clin Oncol 12(11): 2288-2295, 1994.
31. Vathey JN, Marsh R de W, Cendan JC, et al: Arterial therapy of hepatic colorectal metastases. Br J Surg 83(4): 447-455, 1996.